How much does a box of the generic drug Mobotinib (Mobosetinib) cost?
Mobocertinib is a targeted drug used to treat advanced or metastatic non-small cell lung cancer (NSCLC), especially those with EGFR exon 20 insertion mutations. As an oral drug, mobosetinib inhibits the growth and spread of cancer cells by blocking the EGFR signaling pathway. The drug has shown promising results in clinical trials, providing a new treatment option for patients who have progressed despite other treatments.
Although Mobotinib has been launched in China, the drug has not yet been included in medical insurance, which makes it difficult for many patients to obtain this drug in China. Domestic patients can choose to consult through hospital pharmacies, but due to limited supply and high prices, many patients may need to seek other purchasing channels.

For those patients who wish to purchase Mobotinib overseas, there are two options: purchase the brand-name drug or a generic version. The original drug is produced by Takeda Pharmaceutical Company of Japan. The price of the Hong Kong version of the original drug is usually around 7,000 to 8,000 yuan per box. Although this price is relatively high, it guarantees the quality and effectiveness of the drug and is the first choice for some patients.
In comparison, the price of generic drugs produced in Laos and Bangladesh is more affordable, usually more than 3,000 yuan per box. Despite their low price, these generic drugs are basically the same as the original drugs in terms of drug ingredients and therapeutic effects, so they are also an important choice for many patients.
When purchasing generic drugs, patients should pay special attention to choosing formal channels to ensure the quality and safety of the drugs. It is recommended that patients purchase through reputable pharmacies or professional overseas purchasing platforms to avoid purchasing fake and shoddy products. Making a balanced choice between price and quality can help patients better manage their treatment.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)